Anthrax immune globulin improves hemodynamics and survival during B. anthracis toxin-induced shock in canines receiving titrated fluid and vasopressor support-Reference-Cited by-同舟云学术

Anthrax immune globulin improves hemodynamics and survival during B. anthracis toxin-induced shock in canines receiving titrated fluid and vasopressor support

Published:2017-10-23 Issue:1 Volume:5 Page:
ISSN:2197-425X
Container-title:Intensive Care Medicine Experimental
language:en
Short-container-title:ICMx

Author:

Suffredini Dante A.,Cui Xizhong,Jaswal Dharmvir,Remy Kenneth E.,Li Yan,Sun Junfeng,Solomon Steven B.,Fitz Yvonne,Moayeri Mahtab,Leppla Stephen,Eichacker Peter Q.

Funder

NIH Clinical Center

National Institute of Allergy and Infectious Diseases

U.S. Food and Drug Administration

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40635-017-0159-9.pdf

Reference42 articles.

1. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ (2011) Anthrax infection. Am J Respir Crit Care Med 184:1333–1341

2. Pezard C, Berche P, Mock M (1991) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59:3472–3477

3. Cui X, Li Y, Li X, Laird MW, Subramanian M, Moayeri M, Leppla SH, Fitz Y, Su J, Sherer K, Eichacker PQ (2007) Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis 195:572–580

4. Sweeney DA, Cui X, Solomon SB, Vitberg DA, Migone TS, Scher D, Danner RL, Natanson C, Subramanian GM, Eichacker PQ (2010) Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. J Infect Dis 202:1885–1896

5. Warfel JM, Steele AD, D’Agnillo F (2005) Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 166:1871–1881

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models;Toxins;2021-01-13